GL1X · GenesisL1 explorer

Research workbench

Crystal structure of I83E meditope-enabled trastuzumab with azido- meditope

Analyse Crystal structure of I83E meditope-enabled trastuzumab with azido- meditope in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5U5M
Type
protein
Length
566 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Memab trastuzumab, light chain; Memab trastuzumab, heavy chain; Protein L; Immunoglobulin…
UniProt
Q51918, Q2UW42
Ligands
ACE, MRY
Pockets
6 · best druggability 0.60

Structure

x-ray diffraction · 5 distinct chains · 17% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMemab trastuzumab, light chainprotein2147% helix, 51% strand—
BMemab trastuzumab, heavy chainprotein2239% helix, 54% strand—
EProtein Lprotein6335% helix, 44% strandQ51918
CImmunoglobulin G binding protein aprotein5478% helix, 0% strandQ2UW42
DAzido-PEG4-meditopeprotein120% helix, 50% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, E, D
  • MRY · Meso-erythritol · ligand · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14100.600.7647MRY
21620.590.8328empty
32630.540.7644empty
41920.460.7532empty
5740.430.8119empty

Interfaces

6 interfaces between chains.

  • A–B · 2034 Ų buried · 18 hydrogen bonds · protein-protein
  • A–E · 716 Ų buried · 11 hydrogen bonds · protein-protein
  • B–D · 647 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 596 Ų buried · 10 hydrogen bonds · protein-protein
  • A–D · 520 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 2 modified, 1 covalent (disulfide, nonstandard, covalent ligand).

Compared structures

  • 5U5M · Crystal structure of I83E meditope-enabled trastuzumab with azido-meditope · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.